1. Home
  2. TILE vs IMCR Comparison

TILE vs IMCR Comparison

Compare TILE & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interface Inc.

TILE

Interface Inc.

HOLD

Current Price

$25.54

Market Cap

1.4B

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$30.89

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TILE
IMCR
Founded
1973
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
TILE
IMCR
Price
$25.54
$30.89
Analyst Decision
Buy
Buy
Analyst Count
1
12
Target Price
$36.00
$61.82
AVG Volume (30 Days)
624.4K
360.0K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
0.31%
N/A
EPS Growth
32.43
30.39
EPS
1.96
N/A
Revenue
$1,386,854,000.00
$249,428,000.00
Revenue This Year
$7.00
$14.57
Revenue Next Year
$5.46
$8.21
P/E Ratio
$13.08
N/A
Revenue Growth
5.41
43.05
52 Week Low
$17.31
$23.15
52 Week High
$35.11
$40.71

Technical Indicators

Market Signals
Indicator
TILE
IMCR
Relative Strength Index (RSI) 36.14 47.81
Support Level $24.72 N/A
Resistance Level $27.13 $34.35
Average True Range (ATR) 0.92 1.20
MACD 0.12 0.07
Stochastic Oscillator 31.22 67.27

Price Performance

Historical Comparison
TILE
IMCR

About TILE Interface Inc.

Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment. Its products include: ESD, Acoustic, Extreme Wear, and Quick Installation System (nTx).

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: